Skip to main content

Ardent Health, Inc.

For the period ended Nov 4, 2026. Filed Nov 4, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 4, 2026 · Filed Nov 4, 2026

Use the contents to explore the available documents and sections.

ARDT$17.30+8.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Operating Statistics

Operating Statistics

(Unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2026% Change20252026% Change2025
Total revenue (in thousands)$1,624,8563.1%$1,576,746$4,848,9712.7%$4,719,260
Hospitals operated (at period end) (1)300.0%30300.0%30
Licensed beds (at period end) (2)4,2810.0%4,2814,2810.0%4,281
Utilization of licensed beds (3)49%0.0%49%50%0.0%50%
Admissions (4)41,8990.1%41,862123,935(0.7)%124,786
Adjusted admissions (5)91,9332.9%89,328267,5032.5%261,031
Inpatient surgeries (6)9,250(5.0)%9,73227,612(4.2)%28,822
Outpatient surgeries (7)22,684(0.6)%22,81367,4190.1%67,385
Total surgeries31,934(1.9)%32,54595,031(1.2)%96,207
Emergency room visits (8)163,9091.7%161,198476,973(0.4)%479,069
Patient days (9)193,7730.1%193,558580,125(0.8)%584,510
Total encounters (10)1,627,8393.2%1,577,2814,773,1605.6%4,519,815
Average length of stay (11)4.620.0%4.624.680.0%4.68
Net patient service revenue per adjusted admission (12)$17,3700.7%$17,252$17,8570.6%$17,745

(1)Hospitals operated (at period end). This metric represents the total number of hospitals operated by us at the end of the applicable period, irrespective of

whether the hospital real estate is (i) owned by us, (ii) leased by us or (iii) held through a controlling interest in a JV. This metric includes the managed

clinical operations of the hospital at UT Health North Campus in Tyler, Texas ("UT Health North Campus Tyler"), a hospital owned by The University of

Texas Health Science Center at Tyler, an affiliate of The University of Texas System. Since we only manage the clinical operations of UT Health North

Campus Tyler, the financial results of such entity are not consolidated under Ardent Health, Inc.

(2)Licensed beds (at period end). This metric represents the total number of beds for which the appropriate state agency licenses a facility, regardless of

whether the beds are actually available for patient use.

(3)Utilization of licensed beds. This metric represents a measure of the actual utilization of our inpatient facilities, computed by (i) dividing patient days by

the number of days in each period, and (ii) further dividing that number by average licensed beds, which is calculated by dividing total licensed beds (at

period end) by the number of days in the period, multiplied by the number of days in the period the licensed beds were in existence.

(4)Admissions. This metric represents the number of patients admitted for inpatient treatment during the applicable period.

(5)Adjusted admissions. This metric is used by management as a general measure of combined inpatient and outpatient volume. Adjusted admissions

provides management with a key performance indicator that considers both inpatient and outpatient volumes by applying an inpatient volume measure

(admissions) to a ratio of gross inpatient and outpatient revenue to gross inpatient revenue. Gross inpatient and outpatient revenue reflect gross inpatient

and outpatient charges prior to estimated contractual adjustments, uninsured discounts, implicit price concessions, and other discounts. The calculation of

adjusted admissions is summarized as follows:

Adjusted Admissions=Admissionsx(Gross Inpatient Revenue + Gross Outpatient Revenue)
Gross Inpatient Revenue

(6)Inpatient surgeries. This metric represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management, c-

sections, and certain diagnostic procedures are excluded from inpatient surgeries.

(7)Outpatient surgeries. This metric represents the number of surgeries performed on patients who have not been admitted to our hospitals. Pain

management, c-sections, and certain diagnostic procedures are excluded from outpatient surgeries.

(8)Emergency room visits. This metric represents the total number of patients provided with emergency room treatment during the applicable period.

(9)Patient days. This metric represents the total number of days of care provided to patients admitted to our hospitals during the applicable period.

(10)Total encounters. This metric represents the total number of events where healthcare services are rendered resulting in a billable event during the

applicable period. This includes both hospital and ambulatory patient interactions.

(11)Average length of stay. This metric represents the average number of days admitted patients stay in our hospitals.

(12)Net patient service revenue per adjusted admission. This metric represents net patient service revenue divided by adjusted admissions for the applicable

period. Net patient service revenue reflects gross inpatient and outpatient charges less estimated contractual adjustments, uninsured discounts, implicit

price concessions, and other discounts.

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net income$63,387$1,207$156,564$155,873
Adjusted EBITDA Addbacks:
Income tax expense (benefit)17,638(3,410)42,25538,114
Interest expense15,31713,91440,09742,819
Depreciation and amortization41,05939,156125,387114,666
Noncontrolling interest earnings(18,871)(24,685)(55,299)(65,018)
Loss on extinguishment and modification of debt—7,344—7,344
Other non-operating losses (1)—353—1,130
Cybersecurity Incident recoveries, net (2)(1,000)(2,950)(1,000)(22,655)
Certain legal matters and related costs——2,464—
Enterprise restructuring costs (3)5,3602,84632,1606,043
Exit and acquisition-related costs (4)1,6141,1224,0713,486
Enterprise resource planning system conversion costs (5)5,91369211,6511,319
Equity-based compensation7,3139,67424,19430,183
Loss (income) from disposed operations17(11)(5,860)22
Adjusted EBITDA$137,747$45,252$376,684$313,326
Total revenue$1,624,856$1,576,746$4,848,971$4,719,260
Adjusted EBITDA margin8.5%2.9%7.8%6.6%

(1)Other non-operating losses include losses realized on certain non-recurring events or events that are non-operational in nature.

(2)Cybersecurity Incident recoveries, net primarily represent gains on insurance recovery proceeds associated with the Cybersecurity Incident, net of

incremental information technology and litigation costs. During thethree and nine months ended September 30, 2026, the Company recognized a gain of

$1.0 million associated with the release of an accrual for expected litigation-related related costs.

(3)Enterprise restructuring costs represent expenses related to employee termination benefits of$0.2 million and$2.8 million for the three months ended

September 30, 2026 and 2025, respectively, and$21.5 million and$6.0 million for thenine months ended September 30, 2026 and 2025, respectively, for

position eliminations and executive leadership departures as part of strategic organizational changes, and third-party professional fees and expenses for

advisory services related to enterprise restructuring activities of$5.2 million and$10.7 million for thethree and nine months ended September 30, 2026,

respectively. Employee termination benefit costs reflect severance and related employee benefit expenses associated with a discrete enterprise restructuring

program designed to streamline and improve the Company's organizational structure.

(4)Exit and acquisition-related costs represent penalties and costs incurred for terminating pre-existing contracts at acquired facilities of$0.8 million and$0.2

million for the three months ended September 30, 2026 and 2025, respectively, and$0.9 million and$0.5 million for thenine months ended September 30,

2026 and 2025, respectively, third-party professional fees and expenses incurred in connection with potential and completed acquisitions of$0.6 million for

the three months ended September 30, 2026, and$2.6 million and$0.8 million for thenine months ended September 30, 2026 and 2025, respectively, and

system integration costs for completed acquisitions of$0.2 million and$0.9 million for the three months ended September 30, 2026 and 2025, respectively,

and$0.6 million and$2.2 million for thenine months ended September 30, 2026 and 2025, respectively.

(5)Enterprise resource planning system conversion costs represent various costs incurred related to a single system conversion project to implement a new

project of$5.2 million and$0.6 million for the three months ended September 30, 2026 and 2025, respectively, and$10.7 million and$1.2 million for the

nine months ended September 30, 2026 and 2025, respectively, and contract labor expense directly related to the conversion project of$0.8 million and$0.1

million for the three months ended September 30, 2026 and 2025, respectively, and$1.0 million and$0.1 million for thenine months ended September 30,

2026 and 2025, respectively. These costs do not include post-implementation licensing, maintenance and operating costs associated with the new enterprise

resource planning system.

Three Months Ended September 30, 2026Nine Months Ended September 30, 2026
Net income$63,387$156,564
Adjusted EBITDAR Addbacks:
Income tax expense17,63842,255
Interest expense15,31740,097
Depreciation and amortization41,059125,387
Noncontrolling interest earnings(18,871)(55,299)
Cybersecurity Incident recoveries, net (1)(1,000)(1,000)
Certain legal matters and related costs—2,464
Enterprise restructuring costs (2)5,36032,160
Exit and acquisition-related costs (3)1,6144,071
Enterprise resource planning system conversion costs (4)5,91311,651
Equity-based compensation7,31324,194
Loss (income) from disposed operations17(5,860)
Rent expense payable to REITs (5)41,875125,010
Adjusted EBITDAR$179,622$501,694

(1)Cybersecurity Incident recoveries, net primarily represent gains on insurance recovery proceeds associated with the Cybersecurity Incident, net of

incremental information technology and litigation costs. During thethree and nine months ended September 30, 2026, the Company recognized a gain of

$1.0 million associated with the release of an accrual for expected litigation-related related costs.

(2)Enterprise restructuring costs represent expenses related to employee termination benefits of$0.2 million and$21.5 million for thethree and nine months

ended September 30, 2026, respectively, for position eliminations and executive leadership departures as part of strategic organizational changes, and third-

party professional fees and expenses for advisory services related to enterprise restructuring activities of$5.2 million and$10.7 million for thethree and nine

months ended September 30, 2026, respectively. Employee termination benefit costs reflect severance and related employee benefit expenses associated

with a discrete enterprise restructuring program designed to streamline and improve the Company's organizational structure.

(3)Exit and acquisition-related costs represent penalties and costs incurred for terminating pre-existing contracts at acquired facilities of$0.8 million and$0.9

million for thethree and nine months ended September 30, 2026, respectively, third-party professional fees and expenses incurred in connection with

potential and completed acquisitions of$0.6 million and$2.6 million for thethree and nine months ended September 30, 2026, respectively, and system

integration costs for completed acquisitions of$0.2 million and$0.6 million for thethree and nine months ended September 30, 2026, respectively.

(4)Enterprise resource planning system conversion costs represent various costs incurred related to a single system conversion project to implement a new

project of$5.2 million and$10.7 million for thethree and nine months ended September 30, 2026, respectively, and contract labor expense directly related

to the conversion project of$0.8 million and$1.0 million for thethree and nine months ended September 30, 2026, respectively. These costs do not include

post-implementation licensing, maintenance and operating costs associated with the new enterprise resource planning system.

(5)Rent expense payable to REITs for thethree and nine months ended September 30, 2026 consists of rent expense of$39.0 million and$116.4 million,

respectively, related to the Ventas Master Lease and other lease agreements with Ventas for medical office buildings and rent expense of$2.9 million and

$8.6 million, respectively, related to a lease arrangement with MPT for the lease of Hackensack Meridian Mountainside Medical Center.

(Unaudited; in millions)

Guidance for the Full Year Ending December 31, 2026
Previous GuidanceRevised Guidance
LowHighLowHigh
Net income$202$260$209$254
Adjusted EBITDA Addbacks:
Income tax expense53695669
Interest expense56535654
Depreciation and amortization175170171167
Noncontrolling interest earnings(92)(97)(77)(87)
Cybersecurity Incident recoveries, net (1)(7)(7)(7)(7)
Certain legal matters and related costs3333
Enterprise restructuring costs (2)37323736
Exit and acquisition-related costs (3)5465
Enterprise resource planning system conversion costs (4)17161716
Equity-based compensation42383531
Income from disposed operations(6)(6)(6)(6)
Adjusted EBITDA$485$535$500$535

(1)Cybersecurity Incident recoveries, net primarily represent gains on insurance recovery proceeds associated with the Cybersecurity Incident, net of

incremental information technology and litigation costs.

(2)Enterprise restructuring costs represent expenses related to employee termination benefits for position eliminations and executive leadership departures as

part of strategic organizational changes and third-party professional fees and expenses for advisory services related to enterprise restructuring activities.

These costs reflect severance and related employee benefit expenses associated with a discrete enterprise restructuring program designed to streamline and

improve the Company’s organizational structure.

(3)Exit and acquisition-related costs represent penalties and costs incurred for terminating pre-existing contracts at acquired facilities, third-party professional

fees and expenses incurred in connection with potential and completed acquisitions, and system integration costs for completed acquisitions.

(4)Enterprise resource planning system conversion costs represent various costs incurred related to a single system conversion project to implement a new

project and contract labor expense directly related to the conversion project. These costs do not include post-implementation licensing, maintenance and

operating costs associated with the new enterprise resource planning system.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.